Radiation Exposure Compensation Reauthorization Act of 2026
- Sponsor
- Del. Moylan, James C. [R-GU-At Large]
- Committees
- Energy and Commerce Committee (primary)
- Last action
- Aug 17, 2026
Bottom line
The bill dramatically expands the scope and duration of the Radiation Exposure Compensation Act, aiming to provide more comprehensive financial and medical support to a wider range of individuals and their descendants affected by U.S. nuclear activities.
What it actually does
This bill significantly expands and extends the Radiation Exposure Compensation Act (RECA), broadening eligibility for compensation to include new geographic areas, additional participant groups involved in nuclear testing and cleanup, and more types of cancers and diseases. It increases the base compensation amounts, adds reimbursement for out-of-pocket medical expenses, and streamlines the claims process by allowing affidavits as evidence. The bill also reauthorizes the RECA fund until 2043, mandates several studies on radiation fallout and claimant health, and appropriates substantial funds for Radiation Exposure Screening and Education Program (RESEP) clinics.
Proponents argue
Proponents argue that this bill is a long-overdue moral imperative to address the historical injustices and ongoing health crises faced by communities and individuals exposed to radiation from U.S. nuclear weapons programs and waste. They contend that the expanded eligibility, increased compensation, and medical benefits are essential to provide critical relief to those who have suffered, many of whom were previously excluded or inadequately compensated. Supporters also emphasize the importance of the mandated studies to further understand and acknowledge the full scope of radiation impacts.
Opponents contend
Critics, often focused on fiscal responsibility, may raise concerns about the significant increase in federal spending and potential unfunded liabilities associated with the expanded eligibility and extended program duration. They might question the scientific basis for including all new groups or diseases, or the administrative feasibility of processing a surge in claims, particularly with relaxed evidentiary standards. Concerns could also be raised about the precedent set by such a broad expansion and its long-term financial implications.
The bill is moderately complex due to its numerous amendments to existing law. An informed reader would need approximately 15-20 minutes to read and understand its provisions, which is a reasonable time commitment for a bill of this scope.
Section 2
Expansion of Claims Related to Atmospheric Testing ('Downwinders')
This section significantly expands eligibility for individuals affected by atmospheric nuclear testing. It extends the period of exposure for 'downwinders' from 1962 to 1992, adds the territory of Guam and parts of Colorado and Montana to the list of 'affected areas,' and includes individuals who participated in specific radiological cleanup or response efforts at Enewetak Atoll, Palomares (Spain), and Thule Air Force Base (Greenland).
Supporters argue
Supporters argue that these expansions are critical to rectify past omissions and acknowledge the full geographic and temporal scope of harm caused by U.S. nuclear activities. They contend that residents of these newly included areas and participants in these specific operations suffered significant radiation exposure and deserve the same recognition and compensation as previously covered groups.
Critics contend
Opponents may argue that expanding eligibility to new geographic areas and extending the exposure period so significantly could strain the program's resources and potentially include individuals with less direct or scientifically established links to radiation exposure. They might also raise concerns about the difficulty of verifying claims from events decades in the past.
Tradeoffs
This provision balances the desire for comprehensive justice for all affected by nuclear activities against the challenges of establishing clear causation and managing the fiscal impact of a vastly expanded program.
Section 3
Expansion of Claims Related to Manhattan Project Waste
This section expands the geographic eligibility for individuals affected by Manhattan Project waste. It adds numerous new ZIP codes in Illinois, Washington, Colorado, and Ohio to the list of areas where residents may be eligible for compensation if they contracted a specified disease after physical presence in these areas. It also clarifies that a 'petitioner cohort' can be designated for these claims.
Section 4
Increased Compensation and Medical Benefits
This section significantly increases the compensation amounts for 'downwinders' and individuals affected by Manhattan Project waste. It raises the base compensation from $100,000 to $150,000 for downwinders and from $50,000 to $150,000 for Manhattan Project waste claimants. Crucially, it also adds a new provision for medical benefits, allowing claimants to receive additional compensation for all documented out-of-pocket medical expenses incurred due to their specified disease, not covered by other insurance or programs.
Section 5
Acceptance of Affidavits as Evidence
This section amends RECA to allow the Attorney General to accept written affidavits or declarations as evidence for substantiating various aspects of a claim. This includes employment history (for miners/millers), physical presence in affected areas, participation in testing or cleanup sites (Enewetak, Palomares, Thule), and the contraction of compensable diseases. These affidavits must be made under penalty of perjury and by a person other than the claimant, and are accepted in addition to other material.
Section 6
Allowance for Authorized Agents to File Claims
This section amends RECA to explicitly allow 'authorized agents' to file claims on behalf of exposed individuals, particularly if the individual is deceased or incapacitated. It defines an 'authorized agent' to include executors, conservators, legal guardians, personal representatives, and similarly situated persons determined by the Attorney General. This expands on existing provisions for survivors to file claims.
Section 7
Expansion of Compensable Cancers and Diseases
This section significantly expands the list of 'specified diseases' for which individuals can receive compensation under RECA. It adds renal disease and thyroid diseases to the list for both atmospheric testing and Manhattan Project waste claims. It also adds several specific primary cancers: rectal, prostate, uterine, cervical, and skin cancer, to the list for Manhattan Project waste claims. Furthermore, it removes the age restriction that leukemia onset must occur after 20 years of age for Manhattan Project waste claims.
Section 8
Extension of RECA Fund and Claims Limitations
This section reauthorizes the Radiation Exposure Compensation Act (RECA) fund and extends the deadline for submitting claims. It strikes '2028' and inserts '2043' for the authorization of the fund, and strikes '2027' and inserts '2042' for the limitation on claims. This effectively extends the program's operation and claims period by 15 years.
Section 9
Retroactive Application for Previously Successful Claimants
This section allows any claimant who received compensation under RECA before the bill's enactment date to submit a request for additional compensation and benefits. The Attorney General is required to pay these claimants the difference between what they previously received and what they are now eligible for under the amended Act. Additionally, claimants previously compensated under Section 4 (downwinders) will now be eligible for the new medical benefits (reimbursement for out-of-pocket medical expenses).
Section 10
Discretionary Authority for Designating Additional Classes of Individuals
This section establishes a new process for the President, upon recommendation from the Attorney General, to designate additional classes of individuals as eligible for RECA compensation. The Attorney General's advice must be based on exposure assessments by radiation health professionals and information from relevant federal agencies. The President can designate new classes if they are not currently covered, there's a reasonable likelihood of health endangerment from radiation dose, and it aligns with RECA's purposes. It also sets deadlines for agency recommendations and presidential determinations.
Section 13
Funding and Geographical Distribution for RESEP Clinics
This section appropriates significant funds for the Radiation Exposure Screening and Education Program (RESEP) clinics from Fiscal Year 2027 through 2041, totaling over $200 million. It also mandates specific geographical distribution for these grants, ensuring a minimum number of clinics in states like Utah, Idaho, Arizona, Nevada, Colorado, Montana, Missouri, Kentucky, Tennessee, Guam, Washington, Ohio, and New Mexico. Additionally, it requires at least four awards to be made for the operation of mobile units in rural areas of these states/territories.
Removes the requirement that for leukemia claims related to Manhattan Project waste, the initial exposure must have occurred after 20 years of age.
Section 10(a)
Why it matters:This is a technical amendment to an existing eligibility criterion, which is standard legislative practice. It's not intentionally hidden but requires close reading of the statutory changes.
Case for: Supporters argue that the age 20 restriction for leukemia claims was arbitrary and scientifically unfounded, particularly for individuals exposed to radiation at younger ages who are known to be highly susceptible to leukemia. Its removal ensures that all legitimate leukemia claims are considered.
Case against: No specific opposition is typically raised against removing an arbitrary age restriction for a disease known to be linked to radiation exposure, especially when scientific consensus supports earlier onset in exposed populations.
Estimated impact: Likely makes a small but significant number of previously ineligible leukemia claimants eligible for compensation, potentially increasing federal outlays by millions over time.
States that the amendments made by this Act shall take effect as if included in the enactment of Public Law 119-21.
Section 14
Why it matters:Effective date clauses are standard. The retroactive nature is a substantive policy choice, but its placement is typical for such provisions.
Case for: Proponents argue that making the amendments retroactive to Public Law 119-21 (a previous RECA reauthorization) ensures that all individuals who would have been eligible under the expanded criteria since that date can now claim compensation. This prevents a gap in coverage and ensures fairness for those who suffered during the interim.
Case against: Opponents might point to the increased administrative complexity and fiscal burden of processing claims retroactively. This could lead to a surge in claims and require significant resources to re-evaluate past cases or process new ones dating back several years.
Estimated impact: This provision significantly increases the immediate fiscal impact of the bill by making all expanded eligibility and increased compensation retroactive, potentially adding billions to federal outlays for claims that would have been previously denied or underpaid.